Current Assets
Cash & Equivalents
Stryker Cash & Equivalents decreased by 28.2% to $2.88B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 24.1%, from $2.32B to $2.88B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows an upward trend with a 6.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ4 2012
Last reportedQ1 2026May 11, 2026
How to read this metric
Higher levels indicate strong liquidity and financial flexibility, while lower levels may suggest cash burn or aggressive capital deployment.
Detailed definition
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and highly liquid i...
Peer comparison
Peers in the medical device sector typically maintain significant cash balances to support ongoing M&A strategies.
Metric ID:
cash_and_equivalentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.24B | $2.56B | $2.94B | $1.46B | $1.04B | $1.42B | $1.84B | $1.67B | $1.40B | $1.86B | $2.97B | $2.33B | $1.87B | $3.85B | $3.65B | $2.32B | $2.38B | $3.26B | $4.01B | $2.88B |
| QoQ Change | — | +14.4% | +14.9% | -50.5% | -28.4% | +36.0% | +29.9% | -9.4% | -16.2% | +32.8% | +59.7% | -21.6% | -19.6% | +105.4% | -5.1% | -36.5% | +2.4% | +37.1% | +23.2% | -28.2% |
| YoY Change | — | — | — | — | -53.4% | -44.6% | -37.4% | +14.6% | +34.2% | +31.0% | +61.1% | +39.4% | +33.8% | +107.0% | +22.9% | -0.4% | +26.7% | -15.4% | +9.8% | +24.1% |
Range$1.04B – $4.01B
CAGR+5.4%
Avg YoY Growth+15.8%
Median YoY Growth+23.5%
Cash & Equivalents at Other Companies
Frequently Asked Questions
- What is Stryker's cash & equivalents?
- Stryker (SYK) reported cash & equivalents of $2.88B in Q1 2026.
- How has Stryker's cash & equivalents changed year-over-year?
- Stryker's cash & equivalents increased by 24.1% year-over-year, from $2.32B to $2.88B.
- What is the long-term trend for Stryker's cash & equivalents?
- Over 5 years (2020 to 2025), Stryker's cash & equivalents has grown at a 6.4% compound annual growth rate (CAGR), from $2.94B to $4.01B.
- What does cash & equivalents mean?
- The total amount of cash and highly liquid assets the company has available for immediate use.